Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on: January 16,2024

Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on:January 16,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on: January 22,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on:January 22,2024

Serum microRNAs as new criteria for referral to early palliative care services in advanced cancer patients

by Impact Journals LLCROC curves for detecting the early deterioration group. Credit: 2022 Miura et al.A major obstacle to the implementation of early palliative care (EPC) is the lack of objective cr

Updated on: January 15,2024

Serum microRNAs as new criteria for referral to early palliative care services in advanced cancer patients

by Impact Journals LLCROC curves for detecting the early deterioration group. Credit: 2022 Miura et al.A major obstacle to the implementation of early palliative care (EPC) is the lack of objective cr

Updated on:January 15,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on: February 23,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on:February 23,2024

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c

Updated on: March 06,2024

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c

Updated on:March 06,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Study finds Medicaid expansion improves cancer survival outcomes for young adults

byEmory UniversityCredit: Unsplash/CC0 Public DomainA large first-of-its-kind study reported in theJournal of Clinical Oncologyfinds that expanded Medicaid coverage under the Afforda

Updated on: January 23,2024

Study finds Medicaid expansion improves cancer survival outcomes for young adults

byEmory UniversityCredit: Unsplash/CC0 Public DomainA large first-of-its-kind study reported in theJournal of Clinical Oncologyfinds that expanded Medicaid coverage under the Afforda

Updated on:January 23,2024

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko

Updated on: January 07,2024

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko

Updated on:January 07,2024

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on: September 28,2024

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on:September 28,2024

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal

Updated on: February 18,2024

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal

Updated on:February 18,2024